| Market Capitalization (Millions $) |
31 |
| Shares
Outstanding (Millions) |
36 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-5 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
0 |
Tradeup Acquisition Corp
Estrella Immunopharma Inc is a biotechnology company focused on developing innovative immunotherapies for the treatment of various diseases. The company utilizes advanced technologies and scientific research to target the immune system and leverage its power to fight against diseases such as cancer and autoimmune disorders.
Estrella Immunopharma is dedicated to discovering and developing novel drugs and therapies that can enhance the body's immune response to specifically target and eliminate harmful cells or substances. By harnessing the potential of the immune system, the company aims to offer safe and effective treatments with fewer side effects compared to traditional therapies.
The company is committed to conducting extensive research and clinical trials to validate the efficacy and safety of their immunotherapies. They collaborate with leading academic institutions, research organizations, and industry partners to accelerate the development and bring their products to market.
Estrella Immunopharma's ultimate goal is to make a significant impact in improving patient outcomes and quality of life by providing transformative immunotherapies that address unmet medical needs.
Company Address: 5858 Horton Street Emeryville 95608 CA
Company Phone Number: 318-9098 Stock Exchange / Ticker: NASDAQ ESLA
|
1.78% 